Global Hospital-Acquired Infection Diagnostics Market Report 2022: Featuring Key Players Bayer, Danaher, Pfizer & Others – QNT Press Release

DUBLIN, July 5, 2022 /PRNewswire/ — The “Global Hospital-Acquired Infection Diagnostics Market Size, Share & Industry Trends Analysis Report By Product, By Infection Type, By Application, By Test Type, By End User, By Regional Outlook and Forecast, 2022 – 2028” report has been added to’s offering.

The Global Hospital-Acquired Infection Diagnostics Market size is expected to reach $5.6 billion by 2028, rising at a market growth of 7.8% CAGR during the forecast period.

All across the world, the amount of surgical procedures conducted each year has been steadily increasing, and by the end of the decade, it is predicted to hit a new high. As the need for surgical instruments grows along with the number of surgical procedures performed , the risk of healthcare-associated infections is expected to rise.

A growing understanding of the value of sterilized and disinfected medical tools and devices is expected to help drive demand for nosocomial infection control equipment. Other factors driving sales of hospital obtained infection control systems include the increased frequency of chronic diseases and advances in surgical equipment.

Market Growth Factors:

Increasing awareness among people and healthcare institutions

Except for bacterial spores from inanimate things, disinfection is a technique that destroys the majority or all pathogenic microorganisms. Wet pasteurization or liquid chemicals are used to accomplish it. Several factors have influenced disinfection efficiency, each of which might limit the process’ efficacy. The use of disinfectants in healthcare facilities to protect people doing the medical process that exposes people to the virus is on the rise. During the COVID-19 pandemic, …

Full story available on

Source link

Recommended For You

About the Author: News Center